Skip to content

Standing Cognition and Co-morbidities of POTS Evaluation

Standing Cognition and Co-morbidities of POTS Evaluation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03602482
Acronym
SCOPE
Enrollment
139
Registered
2018-07-26
Start date
2018-06-23
Completion date
2019-12-17
Last updated
2021-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postural Tachycardia Syndrome, Ehlers-Danlos Syndrome

Keywords

postural tachycardia syndrome, cognition

Brief summary

The purpose of this study is to evaluate cognition in patients with postural tachycardia syndrome (POTS) while lying down and standing and to assess the prevalence of hypermobile Ehlers-Danlos Syndrome in POTS.

Interventions

BEHAVIORALStanding

Participants will stand and complete cognitive tests.

BEHAVIORALSupine

Participants will complete cognitive tests while supine.

Sponsors

Dysautonomia International
CollaboratorOTHER
Milton S. Hershey Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Previously diagnosed with POTS, or healthy control * Age between 13-60 years * Participants may be any race, ethnicity, sex, or gender * Able and willing to provide informed consent

Exclusion criteria

* Inability to give, or withdrawal of, informed consent * Age ≤ 13 or ≥ 61 years * Prisoners * Unable to stand

Design outcomes

Primary

MeasureTime frameDescription
Executive Function (Stroop Word-color Test)1 hourTesting scores are normalized using T-scores for predicted values based on age and education for each participant. Scores range from 0 to 100. Higher numbers indicate better cognition. Testing will be performed while participants are supine and standing.

Secondary

MeasureTime frameDescription
Attention Score Using Cogstate Identification Task1 hourScores are measured as speed to complete task with lower numbers indicating faster reaction time. Testing will be performed while participants are supine and standing.
Number of Participants With Hypermobile Ehlers-Danlos Syndrome (hEDS)1 hourhEDS was evaluated using the Diagnostic Criteria for hEDS checklist. The number of participants who fulfill the diagnostic criteria on the checklist are reported.
Heart Rate Standing Minus Heart Rate Supine1 hourHeart rate (HR) will be measured using an arm blood pressure cuff while participants are in supine and standing postures. The difference in heart rate (HR standing - HR supine) was calculated for each participant.

Countries

United States

Participant flow

Recruitment details

100 participants with POTS were recruited at the 2018 Dysautonomia International Conference in June 2018 in Nashville, TN. 39 Healthy participants were enrolled at Penn State Hershey Medical Center from August 2018- December 2019,

Pre-assignment details

Participants with odd study IDs completed cognitive testing while supine first. Participants with even study IDs completed cognitive testing standing first.

Participants by arm

ArmCount
POTS
Participants previously diagnosed with postural orthostatic tachycardia syndrome who were able to stand unassisted were enrolled
100
Control
Healthy volunteers that were free of chronic illness were enrolled
39
Total139

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyWithdrawal by Subject6700

Baseline characteristics

CharacteristicTotalPOTSControl
Age, Categorical
<=18 years
17 Participants15 Participants2 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
122 Participants85 Participants37 Participants
Age, Continuous25 years27 years24 years
education level15 years
STANDARD_DEVIATION 3
15 years
STANDARD_DEVIATION 3
16 years
STANDARD_DEVIATION 2
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants4 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
96 Participants96 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
39 Participants0 Participants39 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
7 Participants4 Participants3 Participants
Race (NIH/OMB)
Black or African American
1 Participants0 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
131 Participants96 Participants35 Participants
Region of Enrollment
United States
139 participants100 participants39 participants
Sex: Female, Male
Female
128 Participants92 Participants36 Participants
Sex: Female, Male
Male
11 Participants8 Participants3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 1390 / 1390 / 1390 / 139
other
Total, other adverse events
0 / 1390 / 1390 / 1390 / 139
serious
Total, serious adverse events
0 / 440 / 430 / 200 / 19

Outcome results

Primary

Executive Function (Stroop Word-color Test)

Testing scores are normalized using T-scores for predicted values based on age and education for each participant. Scores range from 0 to 100. Higher numbers indicate better cognition. Testing will be performed while participants are supine and standing.

Time frame: 1 hour

Population: 13 participants dropped out (by their choice) prior to study visit. Mean and standard deviation scores for each arm are reported.

ArmMeasureGroupValue (MEAN)Dispersion
POTS- Supine, StandingExecutive Function (Stroop Word-color Test)Standing Stroop Scores48 Testing ScoresStandard Deviation 13
POTS- Supine, StandingExecutive Function (Stroop Word-color Test)Supine Stroop Scores45 Testing ScoresStandard Deviation 10
POTS- Standing, SupineExecutive Function (Stroop Word-color Test)Supine Stroop Scores54 Testing ScoresStandard Deviation 12
POTS- Standing, SupineExecutive Function (Stroop Word-color Test)Standing Stroop Scores49 Testing ScoresStandard Deviation 10
Control- Supine, StandingExecutive Function (Stroop Word-color Test)Standing Stroop Scores50 Testing ScoresStandard Deviation 6
Control- Supine, StandingExecutive Function (Stroop Word-color Test)Supine Stroop Scores55 Testing ScoresStandard Deviation 10
Control- Standing, SupineExecutive Function (Stroop Word-color Test)Standing Stroop Scores58 Testing ScoresStandard Deviation 9
Control- Standing, SupineExecutive Function (Stroop Word-color Test)Supine Stroop Scores56 Testing ScoresStandard Deviation 10
Secondary

Attention Score Using Cogstate Identification Task

Scores are measured as speed to complete task with lower numbers indicating faster reaction time. Testing will be performed while participants are supine and standing.

Time frame: 1 hour

Population: 13 participants dropped out (by their choice) prior to study visit. Mean and standard deviation scores for each arm are reported.

ArmMeasureGroupValue (MEAN)Dispersion
POTS- Supine, StandingAttention Score Using Cogstate Identification TaskID test speed standing2.78 reaction time (milliseconds)Standard Deviation 0.11
POTS- Supine, StandingAttention Score Using Cogstate Identification TaskID test speed supine2.74 reaction time (milliseconds)Standard Deviation 0.09
POTS- Standing, SupineAttention Score Using Cogstate Identification TaskID test speed supine2.64 reaction time (milliseconds)Standard Deviation 0.4
POTS- Standing, SupineAttention Score Using Cogstate Identification TaskID test speed standing2.78 reaction time (milliseconds)Standard Deviation 0.12
Control- Supine, StandingAttention Score Using Cogstate Identification TaskID test speed standing2.70 reaction time (milliseconds)Standard Deviation 0.05
Control- Supine, StandingAttention Score Using Cogstate Identification TaskID test speed supine2.71 reaction time (milliseconds)Standard Deviation 0.06
Control- Standing, SupineAttention Score Using Cogstate Identification TaskID test speed standing2.68 reaction time (milliseconds)Standard Deviation 0.06
Control- Standing, SupineAttention Score Using Cogstate Identification TaskID test speed supine2.70 reaction time (milliseconds)Standard Deviation 0.06
Secondary

Heart Rate Standing Minus Heart Rate Supine

Heart rate (HR) will be measured using an arm blood pressure cuff while participants are in supine and standing postures. The difference in heart rate (HR standing - HR supine) was calculated for each participant.

Time frame: 1 hour

Population: The change in heart rate (HR standing - HR supine) was calculated for each participant. Mean and standard deviation changes in heart rate (standing HR - supine HR) are reported for each study arm.

ArmMeasureValue (MEAN)Dispersion
POTS- Supine, StandingHeart Rate Standing Minus Heart Rate Supine15 beats/minuteStandard Deviation 10
POTS- Standing, SupineHeart Rate Standing Minus Heart Rate Supine12 beats/minuteStandard Deviation 8
Secondary

Number of Participants With Hypermobile Ehlers-Danlos Syndrome (hEDS)

hEDS was evaluated using the Diagnostic Criteria for hEDS checklist. The number of participants who fulfill the diagnostic criteria on the checklist are reported.

Time frame: 1 hour

Population: The number of participants who had hEDS are reported. This assessment was performed without respect to position (standing/supine) and only in POTS participants. Nine POTS participants did not complete this portion of the study. Healthy controls were not included in this outcome measure.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
POTS- Supine, StandingNumber of Participants With Hypermobile Ehlers-Danlos Syndrome (hEDS)28 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026